Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dynavax Technologies
(NQ:
DVAX
)
11.22
-0.04 (-0.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dynavax Technologies
< Previous
1
2
3
4
5
6
Next >
Jim Cramer On This Stock Up 2% Over 6 Months: 'You've Got A Real Winner There'
January 20, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Weyerhaeuser Co (NYSE: WY) a lot.
Via
Benzinga
The 7 Most Undervalued Long-Term Stocks to Buy in January
January 14, 2023
Investors should keep an eye on these severely undervalued long-term stocks as we get deeper into New Year 2023.
Via
InvestorPlace
Our 7 Top Small-Cap Stock Picks for 2023
December 12, 2022
Most of the names on this list of small-cap stock picks for 2023 are ready to rebound from a tough year in the markets.
Via
InvestorPlace
Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
November 30, 2022
Via
Benzinga
Dynavax Technologies (DVAX) Q3 2022 Earnings Call Transcript
November 03, 2022
DVAX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
China-Based COVID-19 Shot Neutralizes Omicron Subvariants
September 20, 2022
Via
Benzinga
Earnings Preview For Dynavax Technologies
November 02, 2022
Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
3 Under-the-Radar Small-Cap Stocks With 100% Upside Potential
October 13, 2022
If under-the-radar small-cap stocks are your jam, I’ve got three selections from the S&P SmallCap 600 that might be right up your alley.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022
September 27, 2022
Upgrades
Via
Benzinga
Short Interest Sector Focus: Healthcare Sector
September 26, 2022
As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
September 20, 2022
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Via
Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
Via
Benzinga
Dynavax's Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations
August 25, 2022
Hong Kong-listed Clover Biopharmaceuticals Ltd announced data from a global Phase 2/3 trial evaluating its COVID-19 vaccine candidate, SCB-2019, in adolescents (aged 12 to 17 years).
Via
Benzinga
Rocket Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
August 11, 2022
On Thursday, Rocket Pharmaceuticals stock received an upgrade to its Relative Strength (RS) Rating, from 88 to 94.
Via
Investor's Business Daily
Kura Oncology Stock Joins Rank Of Stocks With RS Ratings Over 90
August 08, 2022
On Monday, Kura Oncology stock had its Relative Strength (RS) Rating upgraded to 91, up from 85 a day earlier.
Via
Investor's Business Daily
Dynavax Technologies: Q2 Earnings Insights
August 04, 2022
Dynavax Technologies (NASDAQ:DVAX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Keep Amphastar Pharmaceuticals Stock On Your Watch List Ahead Of Earnings
July 26, 2022
IBD 50 member Amphastar Pharmaceuticals stock is expected to report on Aug. 9 and is trading approximately 12% below a 42.41 entry.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's After-Market Session
July 25, 2022
Gainers
Via
Benzinga
Crispr Therapeutics Stock Shows Rising Price Performance With Jump To 94 RS Rating
July 15, 2022
Crispr Therapeutics sees its Relative Strength Rating enter the elite 90-plus level.
Via
Investor's Business Daily
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
July 15, 2022
The group has several commonalities, including strong ratings and promising charts.
Via
Investor's Business Daily
Prometheus Biosciences Stock Shows Rising Relative Strength
July 14, 2022
Prometheus Biosciences stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase from 72 to 90.
Via
Investor's Business Daily
Merus Stock Joins Rank Of Stocks With RS Ratings Over 90
July 14, 2022
On Thursday, Netherlands-based Merus stock had its Relative Strength (RS) Rating upgraded to 94 from 78 a day earlier.
Via
Investor's Business Daily
Apellis Pharmaceuticals Stock Scores Relative Strength Rating Upgrade
July 13, 2022
ApellisPharmaceuticals sees its Relative Strength Rating reach the elite 90-plus level.
Via
Investor's Business Daily
Vir Biotechnology Stock Joins Rank Of Stocks With RS Ratings Over 90
July 11, 2022
On Monday, Vir Biotechnology stock had its Relative Strength (RS) Rating upgraded to 91 Monday, up from 85 a day earlier.
Via
Investor's Business Daily
Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8%
July 11, 2022
Among its other key ratings, Amsterdam-based gene therapy company Uniqure stock also has a 92 Composite Rating.
Via
Investor's Business Daily
Kezar Life Sciences Stock Shows Rising Market Leadership: Earns 81 RS Rating
July 08, 2022
The Relative Strength (RS) Rating for Kezar Life Sciences stock jumped into a new percentile Friday, with a rise from 78 to 81.
Via
Investor's Business Daily
Apellis Pharmaceuticals Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
July 08, 2022
Apellis Pharmaceuticals stock saw its Relative Strength (RS) Rating upgraded to 85 Friday, up from 79 a day earlier.
Via
Investor's Business Daily
7 Small-Cap Stocks to Buy in July 2022
July 04, 2022
These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.